# Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls

> **NCT04920526** · — · UNKNOWN · sponsor: **Kenya Medical Research Institute** · enrollment: 135 (estimated)

## Conditions studied

- HPV-Related Carcinoma

## Interventions

- **DRUG:** Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine

## Key facts

- **NCT ID:** NCT04920526
- **Lead sponsor:** Kenya Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2021-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04920526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04920526, "Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04920526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*